PAS
PMVP icon

Point72 Asia (Singapore)’s PMV Pharmaceuticals PMVP Stock Holding History

Point72 Asia (Singapore)’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,603
Closed -$49.2K – 1133
2024
Q4 		$49.2K Buy
32,603
+413
+1% +$654 0.01% 515
2024
Q3 		$48K Sell
32,190
-30,444
-49% -$47K 0.01% 701
2024
Q2 		$101K Buy
+62,634
New +$113K 0.02% 485

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asia (Singapore)'s PMVP Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of PMV Pharmaceuticals (PMVP) in Q1 2025, closing a stake of 32,603 shares — an estimated $49.2K sold.

Point72 Asia (Singapore) first reported a position in PMVP in Q2 2024 and held it in 3 quarters. The position peaked at $101K in Q2 2024. 55 funds tracked by Wall St. Rank hold PMVP as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining PMV Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 32,603 PMV Pharmaceuticals shares in Q1 2025, an estimated $49.2K.
  • Point72 Asia (Singapore) first reported a position in PMV Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s PMV Pharmaceuticals position peaked at $101K in Q2 2024.
  • 55 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.